Quarterly Result29 Jul 2026, 09:00 pm
Piramal Pharma Declares Unaudited Q1 FY27 Results
AI Summary
Piramal Pharma Ltd announced its unaudited financial results for the first quarter of FY27, ended June 30, 2026. The Board of Directors approved the standalone and consolidated financial results. The company also confirmed that limited review reports by the statutory auditors have been enclosed. These results will be published in newspapers as per SEBI Listing Regulations and are also available on the company's website. The Board meeting commenced at 5:30 pm and concluded at 8:30 pm.
Key Highlights
- Piramal Pharma declared unaudited financial results for Q1 FY27.
- Results are both standalone and consolidated.
- Limited review reports from statutory auditors are enclosed.
- Financial results will be published in newspapers.
- Information available on the company website.
Price Impact
More from PPLPHARMA